These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6414195)

  • 1. The lysate from bovine erythrocytes infected with Babesia bovis. Analysis of antigens and a report on their immunogenicity when polymerized with glutaraldehyde.
    Goodger BV; Wright IG; Waltisbuhl DJ
    Z Parasitenkd; 1983; 69(4):473-82. PubMed ID: 6414195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babesia bovis: vaccination studies with three groups of high molecular weight antigens from lysate of infected erythrocytes.
    Waltisbuhl DJ; Goodger BV; Wright IG; Mirre GB; Commins MA
    Parasitol Res; 1987; 73(4):319-23. PubMed ID: 3303020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Babesia bovis: vaccination of cattle against heterologous challenge with fractions of lysate from infected erythrocytes.
    Goodger BV; Commins MA; Wright IG; Mirre GB
    Z Parasitenkd; 1984; 70(3):321-9. PubMed ID: 6429962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Babesia bovis: vaccination trial with a dominant immunodiffusion antigen in splenectomised calves.
    Goodger BV; Commins MA; Wright IG; Mirre GB; Waltisbuhl DJ; White M
    Z Parasitenkd; 1986; 72(6):715-22. PubMed ID: 3099492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Babesia bovis: dextran sulphate as an adjuvant for and precipitant of protective immunogens.
    Goodger BV; Waltisbuhl DJ; Commins MA; Wright IG
    Int J Parasitol; 1992 Jul; 22(4):465-9. PubMed ID: 1644521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Babesia bovis: isolation of a protective antigen by using monoclonal antibodies.
    Wright IG; White M; Tracey-Patte PD; Donaldson RA; Goodger BV; Waltisbuhl DJ; Mahoney DF
    Infect Immun; 1983 Jul; 41(1):244-50. PubMed ID: 6345394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective vaccination against virulent Babesia bovis with a low-molecular-weight antigen.
    Wright IG; Mirre GB; Rode-Bramanis K; Chamberlain M; Goodger BV; Waltisbuhl DJ
    Infect Immun; 1985 Apr; 48(1):109-13. PubMed ID: 3980077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of Babesia bigemina-immune animals against subsequent challenge with virulent Babesia bovis.
    Wright IG; Goodger BV; Leatch G; Aylward JH; Rode-Bramanis K; Waltisbuhl DJ
    Infect Immun; 1987 Feb; 55(2):364-8. PubMed ID: 3542832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of Babesia bovis by in vitro cultivation.
    Yunker CE; Kuttler KL; Johnson LW
    Vet Parasitol; 1987 Apr; 24(1-2):7-13. PubMed ID: 3590611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with
    Bastos RG; Laughery JM; Ozubek S; Alzan HF; Taus NS; Ueti MW; Suarez CE
    Front Immunol; 2022; 13():1045608. PubMed ID: 36466866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia bovis: immunity induced by vaccination with a lipid enriched fraction.
    Goodger BV; Commins MA; Waltisbuhl DJ; Wright IG; Rode-Bramanis K
    Int J Parasitol; 1990 Aug; 20(5):685-7. PubMed ID: 2228430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
    Montenegro-James S
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.
    Kuttler KL; Zaugg JL; Yunker CE
    Vet Parasitol; 1988 Mar; 27(3-4):239-44. PubMed ID: 3285573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of cattle with dextran sulphate-binding Babesia bigemina antigens.
    Kung'u MW; Goodger BV; Bushell GR; Wright IG; Waltisbuhl DJ
    Int J Parasitol; 1992 Aug; 22(5):621-5. PubMed ID: 1399246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of cattle with a Babesia bigemina antigen in Freund's complete adjuvant.
    Kuttler KL; Johnson LW
    Am J Vet Res; 1980 Apr; 41(4):536-8. PubMed ID: 7406273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update of the isolation and characterization of culture-derived soluble antigens of Babesia bovis.
    James MA
    Vet Parasitol; 1984 Jun; 14(3-4):231-7. PubMed ID: 6382780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.